COMPARATIVE CYTOPROTECTIVE EFFECT OF DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKERS AGAINST THE TOXICITY OF OXIDIZED LOW-DENSITY-LIPOPROTEIN FOR CULTURED LYMPHOID-CELLS

被引:11
作者
NEGRESALVAYRE, A [1 ]
FITOUSSI, G [1 ]
TROLY, M [1 ]
SALVAYRE, R [1 ]
机构
[1] UNIV TOULOUSE 3,FAC MED,METAB DIS SECT,DEPT BIOCHEM,F-31062 TOULOUSE,FRANCE
关键词
D O I
10.1016/0006-2952(92)90683-A
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ability of dihydropyridine Ca2+ channel blockers (nicardipine, nimodipine and nisoldipine) to inhibit low density lipoprotein (LDL) oxidation and to prevent the cytotoxicity of oxidized LDL for lymphoid cells have been compared. The lipid peroxidation of LDL promoted either by UV radiation or by copper ions was inhibited (antioxidant effect) in a dose-dependent manner by nisoldipine (IC50 values were evaluated at around 10 muM), whereas nimodipine was less potent (IC50 around 50-100 muM) and nicardipine almost inactive. The cytotoxicity of LDL treated (by UV or by copper) in the presence of effective antioxidant concentrations of dihydropyridine Ca2+ channel blockers was less than that of unprotected oxidized LDL (i.e. LDL oxidized in the absence of any dihydropyridine Ca2+ channel blockers). The inhibition of the cytotoxic effect of LDL oxidized in the presence of dihydropyridine Ca2+ channel blockers correlated well with protection from oxidation by these compounds. Beside this indirect protective effect, dihydropyridine Ca2+ channel blockers exhibit a direct protective effect for cells against the toxicity of previously oxidized LDL. Although complete protection cannot be obtained because of the cytotoxicity of the dihydropyridine compounds per se, the IC50 values were 6 +/- 2 and 80 +/- 20 muM for nisoldipine and nimodipine, respectively. The potential relevance to the prevention of atherogenesis is discussed.
引用
收藏
页码:2379 / 2386
页数:8
相关论文
共 44 条
  • [2] BOYD HC, 1989, AM J PATHOL, V135, P815
  • [3] CALCIUM-ANTAGONISTS PREVENT MONOCYTE AND ENDOTHELIAL CELL-INDUCED MODIFICATION OF LOW-DENSITY LIPOPROTEINS
    BREUGNOT, C
    MAZIERE, C
    AUCLAIR, M
    MORA, L
    RONVEAUX, MF
    SALMON, S
    SANTUS, R
    MORLIERE, P
    LENAERS, A
    MAZIERE, JC
    [J]. FREE RADICAL RESEARCH COMMUNICATIONS, 1991, 15 (02): : 91 - 100
  • [4] LIPOPROTEIN METABOLISM IN THE MACROPHAGE - IMPLICATIONS FOR CHOLESTEROL DEPOSITION IN ATHEROSCLEROSIS
    BROWN, MS
    GOLDSTEIN, JL
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1983, 52 : 223 - 261
  • [5] CHISOLM GM, 1989, AM J CARDIOL, V62, pB20
  • [6] MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN INDUCES MONOCYTE CHEMOTACTIC PROTEIN-1 IN HUMAN ENDOTHELIAL-CELLS AND SMOOTH-MUSCLE CELLS
    CUSHING, SD
    BERLINER, JA
    VALENTE, AJ
    TERRITO, MC
    NAVAB, M
    PARHAMI, F
    GERRITY, R
    SCHWARTZ, CJ
    FOGELMAN, AM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) : 5134 - 5138
  • [7] DEPAULHET AC, 1988, BIOL LIPIDES CHEZ HO, P154
  • [8] FLAVONOIDS INHIBIT THE OXIDATIVE MODIFICATION OF LOW-DENSITY LIPOPROTEINS BY MACROPHAGES
    DEWHALLEY, CV
    RANKIN, SM
    HOULT, JRS
    JESSUP, W
    LEAKE, DS
    [J]. BIOCHEMICAL PHARMACOLOGY, 1990, 39 (11) : 1743 - 1750
  • [9] ULTRAVIOLET-TREATED LIPOPROTEINS AS A MODEL SYSTEM FOR THE STUDY OF THE BIOLOGICAL EFFECTS OF LIPID PEROXIDES ON CULTURED-CELL .1. CHEMICAL MODIFICATIONS OF ULTRAVIOLET-TREATED LOW-DENSITY LIPOPROTEINS
    DOUSSET, N
    NEGRESALVAYRE, A
    LOPEZ, M
    SALVAYRE, R
    DOUSTEBLAZY, L
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1045 (03) : 219 - 223
  • [10] ESTERBAUER H, 1988, ISI ATLAS-BIOCHEM, V1, P311